FR17C1020I1 - - Google Patents

Info

Publication number: FR17C1020I1
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-04-16

Filing date

2017-06-06

Publication date

2020-04-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39717519&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR17C1020(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2017-06-06 Application filed filed Critical

2020-04-10 Application granted granted Critical

2020-04-10 Publication of FR17C1020I1 publication Critical patent/FR17C1020I1/fr

2020-04-10 Publication of FR17C1020I2 publication Critical patent/FR17C1020I2/en

Status Active legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1048—Glycosyltransferases (2.4)
- C12N9/1081—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/99—Glycosyltransferases (2.4) transferring other glycosyl groups (2.4.99)
- C12Y204/99006—N-Acetyllactosaminide alpha-2,3-sialyltransferase (2.4.99.6)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Endocrinology (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Reproductive Health (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Wood Science & Technology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
General Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Immunology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Pregnancy & Childbirth (AREA)
Gynecology & Obstetrics (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

FR17C1020C 2008-04-16 2017-06-06 RECOMBINANT FSH INCLUDING ALPHA 2.3 AND ALPHA 2.6 SIALYLATION Active FR17C1020I2 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US4542408P	2008-04-16	2008-04-16
EP08251528		2008-04-25
EP14178729.1A EP2808340B1 (en)	2008-04-16	2009-04-16	Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation
EP13193214.7A EP2722339A1 (en)	2008-04-16	2009-04-16	Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation
EP09733497.3A EP2268666B1 (en)	2008-04-16	2009-04-16	Recombinant fsh including alpha 2,3- and alpha 2,6-sialylation

Publications (2)

Publication Number	Publication Date
FR17C1020I1 true FR17C1020I1 (en)	2020-04-10
FR17C1020I2 FR17C1020I2 (en)	2020-04-10

Family

ID=39717519

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
FR17C1020C Active FR17C1020I2 (en)	2008-04-16	2017-06-06	RECOMBINANT FSH INCLUDING ALPHA 2.3 AND ALPHA 2.6 SIALYLATION
FR25C1003C Active FR25C1003I1 (en)	2008-04-16	2025-01-16	RECOMBINANT FSH COMPRISING ALPHA 2,3 AND ALPHA 2,6 SIALYLATION
FR25C1025C Active FR25C1025I1 (en)	2008-04-16	2025-07-02	RECOMBINANT FSH COMPRISING ALPHA 2,3 AND ALPHA 2,6 SIALYLATION

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
FR25C1003C Active FR25C1003I1 (en)	2008-04-16	2025-01-16	RECOMBINANT FSH COMPRISING ALPHA 2,3 AND ALPHA 2,6 SIALYLATION
FR25C1025C Active FR25C1025I1 (en)	2008-04-16	2025-07-02	RECOMBINANT FSH COMPRISING ALPHA 2,3 AND ALPHA 2,6 SIALYLATION

Country Status (29)

Country	Link
US (6)	US8951967B2 (en)
EP (7)	EP3045471B1 (en)
JP (7)	JP2011519359A (en)
KR (5)	KR20160056960A (en)
CN (3)	CN105906702A (en)
AR (1)	AR071479A1 (en)
AU (5)	AU2009237479B2 (en)
BR (1)	BRPI0910461B8 (en)
CA (1)	CA2725257A1 (en)
CY (1)	CY1115413T1 (en)
DK (6)	DK2268666T3 (en)
ES (5)	ES2989729T3 (en)
FI (4)	FI4015527T3 (en)
FR (3)	FR17C1020I2 (en)
HR (5)	HRP20140535T1 (en)
HU (9)	HUE068565T2 (en)
IL (2)	IL208538A (en)
LT (8)	LT4015527T (en)
MX (3)	MX348622B (en)
NO (4)	NO2017025I1 (en)
NZ (1)	NZ588381A (en)
PL (6)	PL3144318T3 (en)
PT (6)	PT3098234T (en)
RU (3)	RU2537268C2 (en)
SA (1)	SA109300228B1 (en)
SI (6)	SI3144318T1 (en)
TW (1)	TWI488640B (en)
WO (1)	WO2009127826A1 (en)
ZA (1)	ZA201007373B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI488640B (en)	2008-04-16	2015-06-21	菲瑞茵國際中心股份有限公司	Pharmaceutical preparation
TWI532495B (en) *	2009-10-05	2016-05-11	菲瑞茵國際中心股份有限公司	Pharmaceutical preparation
EP2417982A1 (en)	2010-07-30	2012-02-15	Ferring B.V.	Stabilization of gonadotropins
WO2012016576A1 (en) *	2010-08-04	2012-02-09	Glycotope Gmbh	Improved recombinant human follicle-stimulating hormone
SI2621517T2 (en)	2010-09-29	2023-11-30	Ferring B.V.	Composition for use in treating infertility
US20130224797A1 (en)	2010-10-15	2013-08-29	Jcr Pharmaceuticals Co., Ltd.	Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain
CN103619358B (en)	2011-03-31	2017-02-15	辉凌公司	Pharmaceutical preparation
AR090095A1 (en)	2011-06-06	2014-10-22	Ferring Bv	PHARMACEUTICAL PREPARATION THAT INCLUDES STIMULATING HORMONE OF THE RECOMBINANT FOLICLE
JO3092B1 (en)	2011-08-08	2017-03-15	Ferring Bv	Complex for controlled stimulation of the ovary
WO2013093760A2 (en) *	2011-12-19	2013-06-27	Grifols, S.A.	Compositions, methods, and kits for preparing sialylated recombinant proteins
JP6279466B2 (en) *	2012-04-27	2018-02-14	Ｊｃｒファーマ株式会社	New expression vector
EP2824176A1 (en) *	2013-07-11	2015-01-14	Siamed'xpress	Methods for producing sialylated therapeutic proteins
JP6652334B2 (en) *	2014-05-31	2020-02-19	Ｊｃｒファーマ株式会社	Medium containing uridine and N-acetyl-D-mannosamine
WO2016102436A1 (en) *	2014-12-22	2016-06-30	F. Hoffmann-La Roche Ag	Cmp-dependent sialidase activity
ES2784625T3 (en)	2015-04-17	2020-09-29	Ferring Bv	FSH for the treatment of infertility
CN115028675A (en)	2015-06-26	2022-09-09	辉凌公司	Method for purification and/or virus inactivation
EP3205719A1 (en) *	2016-02-15	2017-08-16	CEVEC Pharmaceuticals GmbH	Cell lines for producing recombinant glycoproteins with di-antennary n-glycans, methods using the same, and recombinant glycoproteins
GB201603280D0 (en)	2016-02-24	2016-04-13	Ferring Bv	Stable liquid gonadotropin formulation
EP3382014A1 (en) *	2017-03-29	2018-10-03	CEVEC Pharmaceuticals GmbH	Recombinant glycoproteins with reduced antennary fucosylation
EP3441471A1 (en)	2017-08-08	2019-02-13	CEVEC Pharmaceuticals GmbH	Use of constitutively active variants of growth factor receptors as selection makers for the generation of stable producer cell lines
KR20200045543A (en)	2017-09-01	2020-05-04	훼링 비.브이.	Controlled ovarian stimulation composition
DK3787667T3 (en)	2018-04-30	2025-06-16	Ferring Bv	COMPOSITION FOR CONTROLLED OVARIAN STIMULATION
TWI846743B (en)	2018-10-17	2024-07-01	荷蘭商菲林公司	Compositions and methods for controlled ovarian stimulation
WO2021081670A1 (en) *	2019-11-01	2021-05-06	The University Of British Columbia	Compositions and methods for sialylated mucin-type o-glycosylation of therapeutic proteins
TW202237173A (en)	2020-12-09	2022-10-01	荷蘭商菲林公司	Compositions and methods for controlled ovarian stimulation
KR20240167660A (en)	2022-04-01	2024-11-27	훼링 비.브이.	Mixed Protocol for the Treatment of Infertility
EP4531895A1 (en)	2022-05-26	2025-04-09	Ferring B.V.	Compositions and methods for treatment of infertility in males
US20250367262A1 (en)	2022-07-08	2025-12-04	Ferring B.V.	Compositions and methods for intrauterine insemination (iui)
WO2025017533A1 (en)	2023-07-20	2025-01-23	Ferring B.V.	Extended release drug-loaded microparticles

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1206302B (en)	1987-06-26	1989-04-14	Serono Cesare Ist Ricerca	URINARY FOLLICLE-STIMULATING HORMONE
US5541083A (en)	1989-10-24	1996-07-30	The Regents Of The University Of California	Method for producing secretable glycosyltransferases and other golgi processing enzymes
DE69633565T3 (en)	1995-06-15	2013-01-17	Crucell Holland B.V.	PACKAGING SYSTEMS FOR HUMAN, HUMAN ADENOVIRES, FOR USE IN GENE THERAPY
JP3559652B2 (en) *	1996-06-25	2004-09-02	グローリー工業株式会社	Management device for sales settlement system
IL122732A0 (en) *	1997-01-15	1998-08-16	Akzo Nobel Nv	Liquid gonadotropin-containing formulation its preparation and a device containing same
DK1015622T3 (en)	1997-01-16	2004-08-02	Neose Technologies Inc	Practical in vitro sialylation of recombinant glycoproteins
JPH1111665A (en)	1997-06-28	1999-01-19	Shibuya Kogyo Co Ltd	Sterilized pneumatic conveyor device
TWI235158B (en) *	1997-09-01	2005-07-01	Kirin Brewery	Human thrombopoietin produced by human established cell lines, processes foe preparing the same, and pharmaceutical composition comprising the same
JP4975215B2 (en)	1999-05-07	2012-07-11	メルク・セローノ・ソシエテ・アノニム	Gonadotropin
JP2002011665A (en)	2000-06-28	2002-01-15	Sintokogio Ltd	Shot blast equipment monitor system
IL140110A0 (en) *	2000-12-05	2002-02-10	Applied Research Systems	Improvement of homogeneity and secretion of recombinant proteins in mammalian systems
JP2005515974A (en) *	2001-10-22	2005-06-02	アプライドリサーチシステムズエーアールエスホールディングナームロゼフェンノートシャップ	Gonadodropin for follicle formation
EP2292770B1 (en)	2001-10-29	2014-11-26	Crucell Holland B.V.	Methods for producing proteins with predetermined post-translational modifications
DE60224843T2 (en)	2001-12-07	2009-01-08	Crucell Holland B.V.	Production of viruses, virus and vaccines
US20040248784A1 (en) *	2003-06-03	2004-12-09	Marco Filicori	Unitary combinations of FSH and hCG
EP1694351A2 (en) *	2003-12-03	2006-08-30	Neose Technologies, Inc.	Glycopegylated follicle stimulating hormone
ATE476666T1 (en)	2004-02-04	2010-08-15	Centre Nat Rech Scient	METHOD FOR IDENTIFYING GLYCOFORM-SPECIFIC ANTIBODIES
US8609370B2 (en) *	2004-02-13	2013-12-17	Glycotope Gmbh	Highly active glycoproteins-process conditions and an efficient method for their production
TWI488640B (en)	2008-04-16	2015-06-21	菲瑞茵國際中心股份有限公司	Pharmaceutical preparation
TWI532495B (en)	2009-10-05	2016-05-11	菲瑞茵國際中心股份有限公司	Pharmaceutical preparation
EP2417982A1 (en)	2010-07-30	2012-02-15	Ferring B.V.	Stabilization of gonadotropins
US8790322B2 (en)	2010-08-03	2014-07-29	King Saud University	Stoma coat
WO2012016576A1 (en)	2010-08-04	2012-02-09	Glycotope Gmbh	Improved recombinant human follicle-stimulating hormone
SI2621517T2 (en)	2010-09-29	2023-11-30	Ferring B.V.	Composition for use in treating infertility
CN103619358B (en)	2011-03-31	2017-02-15	辉凌公司	Pharmaceutical preparation
AR090095A1 (en)	2011-06-06	2014-10-22	Ferring Bv	PHARMACEUTICAL PREPARATION THAT INCLUDES STIMULATING HORMONE OF THE RECOMBINANT FOLICLE
JO3092B1 (en)	2011-08-08	2017-03-15	Ferring Bv	Complex for controlled stimulation of the ovary
JP2017513853A (en)	2014-04-18	2017-06-01	グリコトープゲーエムベーハー	Controlled ovarian hyperstimulation using an improved recombinant human follicle stimulating hormone

2009
- 2009-04-15 TW TW098112483A patent/TWI488640B/en active
- 2009-04-16 PL PL16194925T patent/PL3144318T3/en unknown
- 2009-04-16 KR KR1020167012148A patent/KR20160056960A/en not_active Ceased
- 2009-04-16 US US12/988,218 patent/US8951967B2/en active Active
- 2009-04-16 MX MX2014011348A patent/MX348622B/en unknown
- 2009-04-16 PL PL21212873.0T patent/PL4015527T3/en unknown
- 2009-04-16 ES ES16179121T patent/ES2989729T3/en active Active
- 2009-04-16 SI SI200932094T patent/SI3144318T1/en unknown
- 2009-04-16 MX MX2010011343A patent/MX2010011343A/en active IP Right Grant
- 2009-04-16 SI SI200931547A patent/SI2808340T1/en unknown
- 2009-04-16 KR KR1020107025581A patent/KR101622944B1/en active Active
- 2009-04-16 RU RU2010141908/10A patent/RU2537268C2/en active
- 2009-04-16 SI SI200931670A patent/SI3045471T1/en unknown
- 2009-04-16 EP EP16158141.8A patent/EP3045471B1/en not_active Revoked
- 2009-04-16 CN CN201510933782.9A patent/CN105906702A/en active Pending
- 2009-04-16 FI FIEP21212873.0T patent/FI4015527T3/en active
- 2009-04-16 ES ES16158141.8T patent/ES2629392T3/en active Active
- 2009-04-16 EP EP16194925.0A patent/EP3144318B1/en active Active
- 2009-04-16 EP EP16179121.5A patent/EP3098234B1/en active Active
- 2009-04-16 FI FIEP16179121.5T patent/FI3098234T3/en active
- 2009-04-16 DK DK09733497.3T patent/DK2268666T3/en active
- 2009-04-16 NZ NZ588381A patent/NZ588381A/en unknown
- 2009-04-16 CN CN201510933827.2A patent/CN105906703A/en active Pending
- 2009-04-16 DK DK16179121.5T patent/DK3098234T3/en active
- 2009-04-16 AR ARP090101333A patent/AR071479A1/en not_active Application Discontinuation
- 2009-04-16 EP EP14178729.1A patent/EP2808340B1/en not_active Revoked
- 2009-04-16 PL PL14178729T patent/PL2808340T3/en unknown
- 2009-04-16 DK DK14178729.1T patent/DK2808340T3/en active
- 2009-04-16 KR KR1020197022294A patent/KR102108377B1/en active Active
- 2009-04-16 KR KR1020187023820A patent/KR20180095140A/en not_active Ceased
- 2009-04-16 PT PT161791215T patent/PT3098234T/en unknown
- 2009-04-16 PT PT212128730T patent/PT4015527T/en unknown
- 2009-04-16 LT LTEP21212873.0T patent/LT4015527T/en unknown
- 2009-04-16 PL PL16158141T patent/PL3045471T3/en unknown
- 2009-04-16 JP JP2011504527A patent/JP2011519359A/en active Pending
- 2009-04-16 WO PCT/GB2009/000978 patent/WO2009127826A1/en not_active Ceased
- 2009-04-16 PT PT161581418T patent/PT3045471T/en unknown
- 2009-04-16 HU HUE16179121A patent/HUE068565T2/en unknown
- 2009-04-16 HR HRP20140535AT patent/HRP20140535T1/en unknown
- 2009-04-16 BR BRPI0910461A patent/BRPI0910461B8/en active IP Right Grant
- 2009-04-16 CN CN200980121391XA patent/CN102066414A/en active Pending
- 2009-04-16 DK DK16158141.8T patent/DK3045471T3/en active
- 2009-04-16 PT PT161949250T patent/PT3144318T/en unknown
- 2009-04-16 HU HUE14178729A patent/HUE030652T4/en unknown
- 2009-04-16 ES ES09733497.3T patent/ES2468318T3/en active Active
- 2009-04-16 DK DK21212873.0T patent/DK4015527T3/en active
- 2009-04-16 DK DK16194925.0T patent/DK3144318T3/en active
- 2009-04-16 PT PT141787291T patent/PT2808340T/en unknown
- 2009-04-16 AU AU2009237479A patent/AU2009237479B2/en active Active
- 2009-04-16 LT LTEP16158141.8T patent/LT3045471T/en unknown
- 2009-04-16 HR HRP20250313TT patent/HRP20250313T1/en unknown
- 2009-04-16 PL PL09733497T patent/PL2268666T3/en unknown
- 2009-04-16 ES ES21212873T patent/ES3023526T3/en active Active
- 2009-04-16 EP EP13193214.7A patent/EP2722339A1/en active Pending
- 2009-04-16 ES ES14178729.1T patent/ES2610277T3/en active Active
- 2009-04-16 LT LTEP16179121.5T patent/LT3098234T/en unknown
- 2009-04-16 SI SI200930931T patent/SI2268666T1/en unknown
- 2009-04-16 PL PL16179121.5T patent/PL3098234T3/en unknown
- 2009-04-16 SI SI200932205T patent/SI3098234T1/en unknown
- 2009-04-16 SI SI200932209T patent/SI4015527T1/en unknown
- 2009-04-16 HU HUE21212873A patent/HUE071059T2/en unknown
- 2009-04-16 KR KR1020177026920A patent/KR20170110741A/en not_active Ceased
- 2009-04-16 MX MX2017007881A patent/MX355457B/en unknown
- 2009-04-16 CA CA2725257A patent/CA2725257A1/en active Pending
- 2009-04-16 RU RU2014141994A patent/RU2682270C2/en active
- 2009-04-16 EP EP21212873.0A patent/EP4015527B1/en active Active
- 2009-04-16 PT PT97334973T patent/PT2268666E/en unknown
- 2009-04-16 EP EP09733497.3A patent/EP2268666B1/en not_active Revoked
- 2009-04-16 HU HUE16158141A patent/HUE033830T2/en unknown
- 2009-04-16 LT LTEP14178729.1T patent/LT2808340T/en unknown
- 2009-04-16 HR HRP20241187TT patent/HRP20241187T1/en unknown
- 2009-04-18 SA SA109300228A patent/SA109300228B1/en unknown
2010
- 2010-10-07 IL IL208538A patent/IL208538A/en active Protection Beyond IP Right Term
- 2010-10-14 ZA ZA2010/07373A patent/ZA201007373B/en unknown
2014
- 2014-01-21 IL IL230571A patent/IL230571A/en active IP Right Grant
- 2014-06-06 CY CY20141100402T patent/CY1115413T1/en unknown
- 2014-06-17 AU AU2014203277A patent/AU2014203277C1/en active Active
- 2014-11-14 US US14/541,852 patent/US9546204B2/en active Active
- 2014-12-25 JP JP2014262056A patent/JP2015120696A/en active Pending
2016
- 2016-08-16 US US15/238,362 patent/US9771407B2/en active Active
- 2016-10-07 JP JP2016198588A patent/JP6486310B2/en active Active
- 2016-11-16 HR HRP20161520TT patent/HRP20161520T1/en unknown
2017
- 2017-05-30 HU HUS1700024C patent/HUS1700024I1/en unknown
- 2017-05-31 HU HUS1700025C patent/HUS1700025I1/en unknown
- 2017-06-05 LT LTPA2017018C patent/LTPA2017018I1/en unknown
- 2017-06-06 NO NO2017025C patent/NO2017025I1/en unknown
- 2017-06-06 FR FR17C1020C patent/FR17C1020I2/en active Active
- 2017-06-23 AU AU2017204259A patent/AU2017204259B2/en active Active
- 2017-06-23 AU AU2017204258A patent/AU2017204258B2/en active Active
- 2017-06-26 HR HRP20170958TT patent/HRP20170958T1/en unknown
- 2017-08-01 JP JP2017148823A patent/JP6762916B2/en active Active
- 2017-08-29 US US15/690,061 patent/US10995128B2/en active Active
- 2017-09-05 AU AU2017225020A patent/AU2017225020B2/en active Active
- 2017-09-27 LT LTPA2017029C patent/LTPA2017029I1/en unknown
- 2017-09-27 HU HUS1700036C patent/HUS1700036I1/en unknown
- 2017-09-28 NO NO2017050C patent/NO2017050I1/en unknown
2018
- 2018-11-08 RU RU2018139379A patent/RU2745557C3/en active Protection Beyond IP Right Term
2019
- 2019-10-25 JP JP2019194476A patent/JP7316905B2/en active Active
2021
- 2021-04-30 US US17/246,348 patent/US11952407B2/en active Active
- 2021-10-27 JP JP2021175403A patent/JP2022031652A/en active Pending
2023
- 2023-12-21 JP JP2023215339A patent/JP2024038000A/en active Pending
2024
- 2024-03-14 US US18/605,381 patent/US12516094B2/en active Active
2025
- 2025-01-15 FI FIC20250003C patent/FIC20250003I1/en unknown
- 2025-01-16 FR FR25C1003C patent/FR25C1003I1/en active Active
- 2025-01-16 NO NO2025006C patent/NO2025006I1/en unknown
- 2025-01-24 LT LTPA2025505C patent/LTPA2025505I1/lt unknown
- 2025-01-28 HU HUS2500008C patent/HUS2500008I1/en unknown
- 2025-07-02 FR FR25C1025C patent/FR25C1025I1/en active Active
- 2025-07-07 LT LTPA2025525C patent/LTPA2025525I1/lt unknown
- 2025-07-07 HU HUS2500029C patent/HUS2500029I1/en unknown
- 2025-07-11 FI FIC20250025C patent/FIC20250025I1/en unknown
- 2025-07-14 NO NO2025032C patent/NO2025032I1/en unknown

Also Published As

Publication number	Publication date
EP3045471B1 (en)	2017-03-29
ES2610277T3 (en)	2017-04-26
HRP20140535T1 (en)	2014-07-18
RU2014141994A (en)	2016-05-10
LT3098234T (en)	2024-09-10
AU2017204258B2 (en)	2017-08-17
PT3144318T (en)	2020-11-04
HUS1700025I1 (en)	2017-06-28
EP3144318B1 (en)	2020-09-23
HUE030652T4 (en)	2017-09-28
HRP20170958T1 (en)	2017-09-22
EP2268666B1 (en)	2014-03-12
HUE030652T2 (en)	2017-05-29
JP6762916B2 (en)	2020-09-30
JP2018021037A (en)	2018-02-08
FIC20250025I1 (en)	2025-07-11
DK2808340T3 (en)	2016-12-05
HUE068565T2 (en)	2025-01-28
FR25C1025I1 (en)	2025-09-19
EP3098234A1 (en)	2016-11-30
IL208538A (en)	2014-03-31
WO2009127826A1 (en)	2009-10-22
RU2745557C3 (en)	2021-12-10
PT3098234T (en)	2024-10-21
HK1146284A1 (en)	2011-05-20
AU2014203277A1 (en)	2014-07-24
DK4015527T3 (en)	2025-04-14
SI2268666T1 (en)	2014-07-31
KR20160056960A (en)	2016-05-20
EP2268666A1 (en)	2011-01-05
FR25C1003I1 (en)	2025-02-28
LT2808340T (en)	2016-11-10
AU2017225020B2 (en)	2019-11-14
HUS1700036I1 (en)	2017-10-30
EP4015527B1 (en)	2025-01-22
HUE071059T2 (en)	2025-07-28
KR102108377B1 (en)	2020-05-08
LTPA2025525I1 (en)	2025-07-25
FI3098234T3 (en)	2024-10-31
JP2011519359A (en)	2011-07-07
HK1199039A1 (en)	2015-06-19
SI4015527T1 (en)	2025-05-30
EP2808340A1 (en)	2014-12-03
HUS2500029I1 (en)	2025-07-28
PL2808340T3 (en)	2017-02-28
MX2010011343A (en)	2011-01-20
PL4015527T3 (en)	2025-05-26
KR20170110741A (en)	2017-10-11
JP6486310B2 (en)	2019-03-20
AU2017204259A1 (en)	2017-07-20
SA109300228B1 (en)	2014-04-08
CA2725257A1 (en)	2009-10-22
NO2025032I1 (en)	2025-07-14
AU2017225020A1 (en)	2017-09-28
PL3045471T3 (en)	2017-10-31
US20210332099A1 (en)	2021-10-28
LTPA2017018I1 (en)	2017-06-26
KR20190092608A (en)	2019-08-07
PT2808340T (en)	2016-11-21
NZ588381A (en)	2012-05-25
US11952407B2 (en)	2024-04-09
DK3144318T3 (en)	2020-12-07
KR20110005863A (en)	2011-01-19
US10995128B2 (en)	2021-05-04
JP2022031652A (en)	2022-02-22
ES2989729T3 (en)	2024-11-27
HUE033830T2 (en)	2018-01-29
ES2629392T3 (en)	2017-08-09
NO2025006I1 (en)	2025-01-16
HRP20250313T1 (en)	2025-05-09
AU2017204259B2 (en)	2017-08-17
US9546204B2 (en)	2017-01-17
HUS1700024I1 (en)	2017-06-28
HUS2500008I1 (en)	2025-02-28
IL208538A0 (en)	2010-12-30
IL230571A (en)	2015-11-30
EP3098234B1 (en)	2024-07-31
DK2268666T3 (en)	2014-05-12
JP2020040956A (en)	2020-03-19
FI4015527T3 (en)	2025-04-29
JP7316905B2 (en)	2023-07-28
US20110105398A1 (en)	2011-05-05
US8951967B2 (en)	2015-02-10
ES3023526T3 (en)	2025-06-02
DK3045471T3 (en)	2017-06-26
RU2537268C2 (en)	2014-12-27
BRPI0910461B8 (en)	2021-05-25
EP2722339A1 (en)	2014-04-23
HRP20241187T1 (en)	2024-12-06
TWI488640B (en)	2015-06-21
PL2268666T3 (en)	2014-08-29
PT4015527T (en)	2025-04-10
JP2024038000A (en)	2024-03-19
EP2808340B1 (en)	2016-08-17
CN105906702A (en)	2016-08-31
PT3045471T (en)	2017-06-14
KR20180095140A (en)	2018-08-24
BRPI0910461B1 (en)	2021-02-23
BRPI0910461A2 (en)	2018-03-27
KR101622944B1 (en)	2016-05-23
SI2808340T1 (en)	2016-12-30
LTPA2025505I1 (en)	2025-02-10
FIC20250003I1 (en)	2025-01-15
LT4015527T (en)	2025-04-10
TW200948378A (en)	2009-12-01
AU2017204258A1 (en)	2017-07-20
BRPI0910461A8 (en)	2018-10-16
PL3144318T3 (en)	2021-02-08
CY1115413T1 (en)	2017-01-04
RU2682270C2 (en)	2019-03-18
MX348622B (en)	2017-06-22
JP2017060476A (en)	2017-03-30
EP3144318A1 (en)	2017-03-22
PL3098234T3 (en)	2025-01-07
NO2017050I1 (en)	2017-09-28
US20240327487A1 (en)	2024-10-03
SI3098234T1 (en)	2024-10-30
CN105906703A (en)	2016-08-31
US9771407B2 (en)	2017-09-26
AR071479A1 (en)	2010-06-23
US12516094B2 (en)	2026-01-06
AU2014203277C1 (en)	2017-07-27
JP2015120696A (en)	2015-07-02
AU2009237479B2 (en)	2014-05-15
SI3045471T1 (en)	2017-07-31
EP4015527A1 (en)	2022-06-22
SI3144318T1 (en)	2020-12-31
US20150065695A1 (en)	2015-03-05
RU2014141994A3 (en)	2018-05-28
EP3045471A1 (en)	2016-07-20
FR17C1020I2 (en)	2020-04-10
US20160347811A1 (en)	2016-12-01
AU2014203277B2 (en)	2017-04-06
CN102066414A (en)	2011-05-18
NO2017025I1 (en)	2017-06-06
AU2009237479A1 (en)	2009-10-22
LT3045471T (en)	2017-07-10
RU2745557C1 (en)	2021-03-29
PT2268666E (en)	2014-06-25
ZA201007373B (en)	2011-06-29
RU2010141908A (en)	2012-05-27
HRP20161520T1 (en)	2016-12-30
MX355457B (en)	2018-04-19
LTPA2017029I1 (en)	2017-10-10
US20180079794A1 (en)	2018-03-22
ES2468318T3 (en)	2014-06-16
DK3098234T3 (en)	2024-10-21

Publication	Publication Date	Title
BRPI0909040A2 (en)	2017-09-19
BRPI0917573A2 (en)	2017-07-11
BRPI0908549B8 (en)	2021-06-08
BRPI0918697A2 (en)	2017-08-29
BRPI0917525A2 (en)	2017-07-04
BRPI0920750A2 (en)	2016-02-02
BRPI0919470A2 (en)	2017-08-22
BRPI0907698A2 (en)	2017-08-22
BRPI0922455A2 (en)	2021-12-28
BRPI0917618A8 (en)	2019-09-10
BRPI0923734A2 (en)	2017-07-11
BRPI0912727A2 (en)	2017-08-29
BRPI0922669A2 (en)	2017-07-11
BRPI0908285A2 (en)	2017-08-29
BRPI0910485A2 (en)	2017-08-29
BRPI0914750A2 (en)	2017-08-15
BRPI0919811A2 (en)	2017-08-29
BRPI0908120A2 (en)	2017-08-22
BRPI0915616A2 (en)	2016-02-02
BRPI0912462A2 (en)	2016-02-02
BRPI0904541A8 (en)	2010-09-21
BRPI0920914A2 (en)	2017-07-11
BRPI0922550A2 (en)	2016-02-02
BRPI0916284A2 (en)	2017-08-08
BRPI0913605A2 (en)	2017-07-25